Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-05-08

Clinical Trial Update: Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating kidney Yin/Yang replenishment in patients with chronic kidney disease and renal osteodystrophy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bing Shu | Conditions: Renal Insufficiency, Chronic, Renal Osteodystrophy | Phase 2 | Status: WITHDRAWN